Skip to main content

Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM)

Quality of Life Research volume 29, pages 2287–2297 (2020)Cite this article

Abstract

Purpose

The aim of the study was to develop a patient-reported outcome measure for patients with sarcoma—the Sarcoma Assessment Measure (SAM).

Methods and results

The systematic development of SAM included a three-stage, mixed-methods study using semi-structured interviews, focus groups and questionnaires, with all stages involving patients from across the United Kingdom. In-depth interviews were conducted with 121 patients (50% male; aged 13–82; with soft tissue sarcoma (62%), bone tumours (28%) and gastrointestinal stromal tumours (10%)). Content analysis of the interview transcripts identified 1415 post-diagnosis experience statements. Experience statements were reviewed, repetition was removed and sentences were refined to form 395 ‘items’ which were included in an Item Reduction Questionnaire (IRQ) grouped as physical, emotional, social and financial wellbeing and sexuality. The IRQ was completed by 250 patients who rated each item on importance and worry. Items with a mean score above 5 (6 in the emotional domain) were removed, which reduced the list to 166 items. After review by the research team, 23 clinicians and 34 patients, 66 items were retained to test content validity. Items with a content validity ratio of < .33 were removed. Cognitive interviews were conducted with 10 patients on the final 22 items to test comprehension. Minor changes were made to four.

Conclusion

SAM comprises of 22 items reflecting physical, emotional, social, financial wellbeing and sexuality. This systematic process of using patient experience to develop the content of SAM will ensure that it measures what is important to patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Furtado, S., Briggs, T., Fulton, J., Russell, L., Grimer, R., Wren, V., et al. (2016). Patient experience after lower extremity amputation for sarcoma in England: a national survey. Disability & Rehabilitation,39, 1171–1190.

    Article  Google Scholar 

  2. Kwong, T. N. K., Furtado, S., & Gerrand, C. (2014). What do we know about survivorship after treatment for extremity sarcoma? A systematic review. European Journal of Surgical Oncology,40(9), 1109–1124.

    Article  Google Scholar 

  3. Storey, L., Fern, L. A., Martins, A., Wells, M., Bennister, L., Gerrand, C., et al. (2019). A critical review of the impact of sarcoma on psychosocial wellbeing. Sarcoma,2019, 9730867.

    Article  Google Scholar 

  4. Davis, A. M., Bell, R. S., Badley, E. M., Yoshida, K., & Williams, J. I. (1999). Evaluating functional outcome in patients with lower extremity sarcoma. Clinical Orthopaedics & Related Research.,358, 90–100.

    Article  Google Scholar 

  5. Skalicky, A. M., Ghate, S. R., Perez, J. R., & Rentz, A. M. (2017). Results of a qualitative study to develop a patient reported outcome measure for patients with 4 subtypes of soft tissue sarcoma. Sarcoma,2017, 6868030.

    Article  Google Scholar 

  6. Bekkering, W. P., Vlieland, T. P. M. V., Koopman, H. M., Schaap, G. R., Schreuder, H. W. B., Beishuizen, A., et al. (2009). The Bt-DUX: development of a subjective measure of health-related quality of life in patients who underwent surgery for lower extremity malignant bone tumor. Pediatric Blood & Cancer,53(3), 348–355.

    Article  Google Scholar 

  7. EORTC. https://qol.eortc.org/. https://qol.eortc.org/. Accessed 11/03 2019.

  8. Pediatric Quality of Life Inventory. https://www.pedsql.org/. https://www.pedsql.org/. Accessed 11/03 2019.

  9. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,85(5), 365–376.

    Article  CAS  Google Scholar 

  10. Davidge, K., Bell, R., Ferguson, P., Turcotte, R., Wunder, J., & Davis, A. M. (2009). Patient expectations for surgical outcome in extremity soft tissue sarcoma. Journal of Surgical Oncology,100(5), 375–381.

    Article  Google Scholar 

  11. Fauske, L., Bondevik, H., Bruland, O. S., & Ozakinci, G. (2015). Negative and positive consequences of cancer treatment experienced by long-term osteosarcoma survivors: A qualitative study. Anticancer Research,35(11), 6081–6090.

    CAS  PubMed  Google Scholar 

  12. Novakovic, B., Fears, T. R., Wexler, L. H., McClure, L. L., Wilson, D. L., McCalla, J. L., et al. (1996). Experiences of cancer in children and adolescents. Cancer Nursing,19(1), 54–59.

    Article  CAS  Google Scholar 

  13. Fauske, L., Bruland, O. S., Grov, E. K., & Bondevik, H. (2015). Cured of primary bone cancer, but at what cost: A qualitative study of functional impairment and lost opportunities. Sarcoma,2015, 1–10.

    Article  Google Scholar 

  14. Fauske, L., Lorem, G., Grov, E. K., & Bondevik, H. (2016). Changes in the body image of bone sarcoma survivors following surgical treatment: A qualitative study. Journal of Surgical Oncology,113(2), 229–234.

    Article  Google Scholar 

  15. Taylor, M. F., & Pooley, J. A. (2017). Sarcoma survivors' perspectives on their body image and functional quality of life post-resection/limb salvage surgery. European Journal of Cancer Care. https://doi.org/10.1111/ecc.12667.

    Article  PubMed  Google Scholar 

  16. Parsons, J. A., Eakin, J. M., Bell, R. S., Franche, R., & Davis, A. M. (2008). 'So, are you back to work yet?' Re-conceptualizing 'work' and 'return to work' in the context of primary bone cancer. Social Science & Medicine,67(11), 1826–1836.

    Article  Google Scholar 

  17. Department of Health. (2010). Equity and excellence: Liberating the NHS. London: The Stationery Office Ltd.

    Google Scholar 

  18. Taylor, R. M., Gibson, F., & Franck, L. S. (2008). The experience of living with a chronic illness during adolescence: A critical review of the literature. Journal of Clinical Nursing,17, 3083–3091.

    Article  Google Scholar 

  19. Lawshe, C. H. (1975). A quantitative approach to content validity. Personnel Psychology,28, 563–575.

    Article  Google Scholar 

  20. Taylor, R. M., Fern, L. A., Solanki, A., Hooker, L., Carluccio, A., Pye, J., et al. (2015). Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer. Health and Quality of Life Outcomes,13, 107.

    Article  Google Scholar 

  21. Bredart, A., Marrel, A., Abetz-Webb, L., Lasch, K., & Acquadro, C. (2014). Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: eliciting patients' experience. Health & Quality of Life Outcomes,12, 15.

    Article  Google Scholar 

  22. Polit, D. F., Beck, C. T., & Owen, S. V. (2007). Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Research in Nursing & Health,30(4), 459–467.

    Article  Google Scholar 

  23. Schilling, L. S., Dixon, J. K., Knafl, K. A., Grey, M., Ives, B., & Lynn, M. R. (2007). Determining content validity of a self-report instrument for adolescents using a heterogeneous expert panel. Nursing Research,56(5), 361–366.

    Article  Google Scholar 

  24. Beatty, P. C., & Willis, G. B. (2007). Research synthesis: The practice of cognitive interviewing. Public Opinion Quarterly,71(2), 287–311.

    Article  Google Scholar 

  25. Martins, A., Whelan, J. S., Bennister, L., Fern, L. A., Gerrand, C., Onasanya, M., et al. (Under review). Experiences of patients with soft-tissue sarcoma: qualitative study. Sarcoma.

  26. Martins, A., Whelan, J. S., Bennister, L., Fern, L. A., Gerrand, C., Onasanya, M., et al. (2019). Qualitative study exploring patients experiences of being diagnosed and living with primary bone cancer in the UK. British Medical Journal Open,9(9), e028693.

    Google Scholar 

  27. Medical, R. C. (2008). Developing and evaluating complex interventions: New guidance. International Journal of Nursing Studies.,50, 587–592.

    Google Scholar 

  28. Crist, J. V., & Grunfeld, E. A. (2013). Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psycho-oncology,22(5), 978–986.

    Article  Google Scholar 

  29. Hall, D. L., Luberto, C. M., Philpotts, L. L., Song, R., Park, E. R., & Yeh, G. Y. (2018). Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis. Psycho-oncology,27(11), 2546–2558.

    Article  Google Scholar 

  30. Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013). Fear of recurrence and disease progression in long-term (%3e= 5 years) cancer survivors: A systematic review of quantitative studies. Psycho-oncology,22(1), 1–11.

    Article  CAS  Google Scholar 

  31. Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., et al. (2013). Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. Journal of Cancer Survivorship,7(3), 300–322.

    Article  Google Scholar 

  32. Walter, F. M., Penfold, C., Joannides, A., Saji, S., Johnson, M., Watts, C., et al. (2019). Missed opportunities for diagnosing brain tumours in primary care: A qualitative study of patient experiences. British Journal of General Practice,69(681), e224–e235.

    Article  Google Scholar 

  33. Zhou, Y., van Melle, M., Singh, H., Hamilton, W., Lyratzopoulos, G., & Walter, F. M. (2019). Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: A systematic review. British Medical Journal Open,9(10), e029143.

    Google Scholar 

  34. Fern, L. A., Martins, A., & Taylor, R. M. (2019). The diagnostic experience of sarcoma patients; secondary analysis of the SAM study. Sarcoma UK, SUK,203, 2018.

    Google Scholar 

Download references

Acknowledgements

Rachel Taylor is a National Institute for Health Research (NIHR) Senior Nurse Research Leader. The views expressed in this article are those of the author and not necessarily those of the NIHR, or the Department of Health and Social Care. The authors would like to thank the following sarcoma teams for recruiting to the study: Dr Fiona Cowie (Beatson Oncology Centre, Glasgow), Dr Helen Hatcher (Cambridge University Hospitals), Dr Dan Stark (Leeds Teaching Hospitals NHS Foundation Trust), Dr Sherron Furtado (Newcastle Upon Tyne Hospitals), Suriya Kirkpatrick (North Bristol NHS Trust), Mr Robert Ashford (Nottingham University Hospitals NHS Foundation Trust and University Hospitals Leicester NHS Trust), Clare McKenzie (Oxford University Hospitals NHS Foundation Trust), Jayne Edwards and Mr Paul Cool (Robert Jones and Agnes Hunt Orthopaedic Hospital), Julie Woodford (Royal National Orthopaedic Hospital), Mr Jonathan Gregory (Royal Orthopaedic Hospital), Dr Robin Young (Sheffield Teaching Hospitals NHS Trust), Dr Mariam Jafri (University Hospitals Birmingham NHS Foundation Trust), Dr Paula Wilson (University Hospitals Bristol NHS Trust), Rebecca Burt (University Hospitals Coventry and Warwickshire NHS Trust), Dr Nicola Keay (University Hospitals Southampton NHS Foundation Trust), Sarah Massey (Royal Liverpool and Broadgreen University Hospitals), Mr Amit Kumar (Central Manchester University Hospital NHS Trust), Prof Jeremy Whelan (University College London Hospitals NHS Foundation Trust).

Funding

This paper presents independent research funded by Sarcoma UK. The views expressed are those of the author(s) and not necessarily those of Sarcoma UK.

Author information

Authors and Affiliations

  1. Cancer Division, University College London Hospitals NHS Foundation Trust, London, NW1 2PG, UK

    Ana Martins, Lorna A. Fern, Jeremy S. Whelan, Rachael Windsor & Rachel M. Taylor

  2. Patient Representative, University College London Hospitals NHS Foundation Trust, London, NW1 2PG, UK

    Lindsey Bennister & Maria Onasanya

  3. London Sarcoma Service, Royal National Orthopaedic Hospital, Stanmore, Middlesex, HA7 4LP, UK

    Craig Gerrand & Julie Woodford

  4. Department of Psychology, Birmingham City University, Curzon Building, Birmingham, B4 7BD, UK

    Lesley Storey

  5. Nursing Directorate, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, W6 8RF, UK

    Mary Wells

  6. UCLH Cancer Clinical Trials Unit, 1st Floor East, 250 Euston Road, London, NW1 2PG, UK

    Rachel M. Taylor

Authors
  1. Ana Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lindsey Bennister
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorna A. Fern
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Craig Gerrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Onasanya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lesley Storey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mary Wells
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jeremy S. Whelan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Rachael Windsor
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Julie Woodford
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rachel M. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All the authors were involved in developing the protocol. AM, RMT coordinated the running of the study and were responsible for data acquisition. All the authors contributed to the analysis. RMT drafted the manuscript. All authors critically revised and approved the final manuscript.

Corresponding author

Correspondence to Rachel M. Taylor.

Ethics declarations

Conflict of interest

The authors have no conflict of interests to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 48 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Martins, A., Bennister, L., Fern, L.A. et al. Development of a patient-reported experience questionnaire for patients with sarcoma: the Sarcoma Assessment Measure (SAM). Qual Life Res 29, 2287–2297 (2020). https://doi.org/10.1007/s11136-020-02481-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-020-02481-x

Keywords

  • Sarcoma
  • Cancer
  • Experience
  • Outcome